Point72 Hong Kong’s GeneDx Holdings WGS Stock Holding History

Point72 Hong Kong’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-45	Closed	-$2K	–	2467
2022 Q2	$2K	Buy	+45	New	+$3.05K	﹤0.01%	1798

Other funds holding WGS

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Point72 Hong Kong's WGS Position: Q3 2022 in Review

Point72 Hong Kong sold out of GeneDx Holdings (WGS) in Q3 2022, closing a stake of 45 shares — an estimated $2K sold.

Point72 Hong Kong first reported a position in WGS in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 98 funds tracked by Wall St. Rank hold WGS as of Q3 2022.

Point72 Hong Kong reported no remaining GeneDx Holdings position as of Q3 2022 after selling out during the quarter.
Point72 Hong Kong sold 45 GeneDx Holdings shares in Q3 2022, an estimated $2K.
Point72 Hong Kong first reported a position in GeneDx Holdings in Q2 2022 and held it in 1 quarter.
Point72 Hong Kong's GeneDx Holdings position peaked at $2K in Q2 2022.
98 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.